Overview

A Pharmacokinetic Study to Compare the Dosing of Valproic Acid in Subjects With Different Body Weights

Status:
Terminated
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the blood levels of valproic acid in subjects with different body weights and to evaluate whether the pharmacokinetic parameters of this drug is altered in the obese population.
Phase:
Phase 4
Details
Lead Sponsor:
Northwell Health
Treatments:
Valproic Acid